![Dominic Smethurst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Smethurst
Corporate Officer/Principal bij
Faculty of Pharmaceutical Medicine
Vermogen: 150 315 $ op 30-06-2026
Profiel
Dominic Smethurst is currently a Member at The Royal College of Physicians and a Member at the Faculty of Pharmaceutical Medicine.
Former roles include Chief Medical Officer at Bicycle Therapeutics Plc from 2020 to 2023, Chief Medical Officer at Nordic Nanovector ASA in 2020, Chief Medical Officer at Tusk Therapeutics Ltd. from 2016 to 2018, Vice President-Oncology & Global Therapeutic Area at ICON plc from 2015 to 2016, Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. from 2024 to 2026, Chief Medical Officer at Oncoinvent ASA, and Venture Partner at SV Health Investors LLP.
Education includes undergraduate studies at the University of Cambridge and graduate studies at Christ's College (United Kingdom).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-03-2026 | 16.025 ( 0,09% ) | 150 315 $ | 30-06-2026 |
Actieve functies van Dominic Smethurst
| Bedrijven | Functie | Begin |
|---|---|---|
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Dominic Smethurst
| Bedrijven | Functie | Einde |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 30-06-2026 |
| BICYCLE THERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 31-03-2023 |
| THOR MEDICAL | Hoofd Techniek/Wetenschap/O&O | 10-08-2020 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-09-2018 |
| ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01-09-2016 |
Opleiding van Dominic Smethurst
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
88
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faculty of Pharmaceutical Medicine | |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Christ's College (United Kingdom)
 Christ's College (United Kingdom) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies MarketScreener 
